Altered sulfite oxidase expression contributes to AMP-activated protein kinase-dependent mitochondrial dysfunction and metabolic dysregulation in polycystic ovary syndrome
Molecular and Cellular Endocrinology · 2026-10 · 620 · 112836
DOI: 10.1016/j.mce.2026.112836 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular and Cellular Endocrinology, 2026-10. Verfasst von Xiaomeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, The Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, China; Qingdao Medical College, Qingdao Univ…. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Polycystic Ovary Syndrome, Mitochondria, Sulfite Oxidase. Die Arbeit nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder characterized by reproductive dysfunction and endocrine-metabolic abnormalities. However, its precise pathogenesis remains unclear. Increasing evidence indicates that ovarian granulosa cells (GCs) dysfunction and metabolic imbalance play critical roles in the initiation and progression of PCOS. This study investigated the regulatory role of the sulfite oxidase (SUOX)-AMP-activated protein kinase (AMPK) signaling axis in the development and function of ovarian GCs in PCOS. METHODS: PCOS-associated gene variants were identified using high-throughput sequencing and subsequently validated using dual-luciferase reporter assays. SUOX expression was modulated in ovarian KGN cells using gene knockdown and overexpression approaches combined with pharmacological interventions to assess alterations in SUOX-AMPK signaling and its downstream effects. A mouse model of PCOS was established to further evaluate the biological role of SUOX in vivo. RESULTS: SUOX expression was significantly reduced in follicular fluid samples from patients with PCOS. SUOX knockdown was associated with suppression of AMPK signaling, mitochondrial dysfunction, impaired autophagy, and increased lipid synthesis in KGN cells. Conversely, SUOX overexpression or AMPK pharmacological activation effectively reversed these pathological changes. Restoration of SUOX expression partially reduced ovarian metabolic dysfunction in PCOS mouse models. CONCLUSION: These findings demonstrate that the SUOX-AMPK signaling axis plays an important role in the pathogenesis of PCOS. Reduced SUOX expression may contribute to disease progression by promoting oxidative stress, worsening mitochondrial damage, and impairing ovarian function, suggesting that SUOX may represent a potential molecular target for the diagnosis and treatment of PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, The Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, China; Qingdao Medical College, Qingdao University, Qingdao, China.
- Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Gynecology, Women and Children's Hospital, Qingdao University, Qingdao, China.
- Department of Obstetrics, The Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, China.
- Department of Obstetrics, The Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, China. Electronic address: wangxiaofei09@126.com.
- Department of Obstetrics, The Affiliated Hospital of Qingdao University, 59 Haier Road, Qingdao, 266000, China. Electronic address: xulinqd@sina.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Zhang, K., Hao, J., Zhao, M., Wang, X., & Xu, L. (2026). Altered sulfite oxidase expression contributes to AMP-activated protein kinase-dependent mitochondrial dysfunction and metabolic dysregulation in polycystic ovary syndrome. Molecular and Cellular Endocrinology, 620, 112836. https://doi.org/10.1016/j.mce.2026.112836
Vancouver
Wang X, Zhang K, Hao J, Zhao M, Wang X, Xu L. Altered sulfite oxidase expression contributes to AMP-activated protein kinase-dependent mitochondrial dysfunction and metabolic dysregulation in polycystic ovary syndrome. Molecular and Cellular Endocrinology. 2026;620:112836. doi:10.1016/j.mce.2026.112836
BibTeX
@article{Wang2026,
author = {Wang, Xiaomeng and Zhang, Kexin and Hao, Juan and Zhao, Min and Wang, Xiaofei and Xu, Lin},
title = {Altered sulfite oxidase expression contributes to AMP-activated protein kinase-dependent mitochondrial dysfunction and metabolic dysregulation in polycystic ovary syndrome},
journal = {Molecular and Cellular Endocrinology},
year = {2026},
volume = {620},
pages = {112836},
doi = {10.1016/j.mce.2026.112836}
}
EUVIMED